This inventor holds 1 USPTO granted patent. Top assignee: William Harvey Research Limited. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Adrian P L Smith
Introduction
Adrian P L Smith is a notable inventor based in London, GB. He has made significant contributions to the field of medical research, particularly in the area of endothelin-1 synthesis. His work has the potential to impact the treatment of various diseases linked to the overproduction of this peptide.
Latest Patents
Adrian P L Smith holds a patent for "Inhibitors of endothelin-1 synthesis." This patent describes sequences in human preproendothelin-1 mRNA that can be targeted by antisense oligonucleotides to inhibit the synthesis of endothelin-1. The inhibition of endothelin-1 synthesis may be utilized to treat diseases where excess production of endothelin-1 is a contributing factor to the symptoms. He has 1 patent to his name.
Career Highlights
Adrian is associated with William Harvey Research Limited, where he conducts his research and development activities. His work is crucial in advancing our understanding of endothelin-1 and its implications in various health conditions.
Collaborations
Throughout his career, Adrian has collaborated with esteemed colleagues such as Roger Corder and Timothy W Higgenbottam. These collaborations have enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
Adrian P L Smith's innovative work in inhibiting endothelin-1 synthesis showcases his commitment to addressing significant health challenges. His contributions are vital for the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile